| 摘要 |
According to the invention the method comprises the following steps: a) providing a biological sample from a person presumably infected with the hepatitis C virus; b) contacting the sample with a reagent comprising a combination of type specific epitopes specific for the hepatitis C virus, at least one epitope of the combination originating in the hepatitis C virus non-structural 4 region and moreover, the contact being achieved under conditions which allow the formation of the first epitope - antibody complexes; and c) assaying for the presence of the epitope - antibody complexes in the sample in order to determine whether the antibodies in the sample bind themselves to the first reagent Additionally, the method also comprises the following steps: d) contacting the sample with a second reagent-type specific epitope specific for the hepatitis C virus, said epitope originating in the hepatitis C virus core region and, moreover, the contact being achieved under conditions which allow the formation of a second epitope - antibody complex; and d) assaying for the presence of the second epitope - antibody complex in the sample in order to determine whether the antibodies in the sample bind themselves to the second reagent
|
